Bgm (BGM) Debt Ratio (2019 - 2025)

Bgm's (BGM) quarterly Debt Ratio came in at 0.0 in Q3 2025, down 99.91% year-on-year from 4.08 in Q3 2024, and down 51.7% on a QoQ basis from 0.01 in Q1 2025.

Bgm (BGM) Debt Ratio (2019 - 2025) Analysis & Trends

Bgm (BGM) has 6 years of Debt Ratio data on file, last reported at 0.0 in Q3 2025.

  • On a quarterly basis, Debt Ratio fell 99.91% year-over-year to 0.0 in Q3 2025; TTM through Sep 2025 was 0.0, a 99.91% decrease from a year earlier, with the FY2025 full-year figure at 0.0, down 99.91% from the prior year.
  • Debt Ratio for Q3 2025 stood at 0.0, down from 0.01 in the prior quarter.
  • Over the last five years, Debt Ratio for BGM reached as high as 39340383870.41 in Q1 2022 and fell as low as 0.0 in Q3 2022.
  • Historically, Debt Ratio has averaged 6556730645.75 across 4 years, with a median of 0.01 in 2023.
  • Across the five-year window, Debt Ratio jumped 43541.29% in 2024 and tumbled 99.91% in 2025, its largest moves.
  • Year by year, Debt Ratio stood at 0.0 in 2022, then jumped by 329.58% to 0.01 in 2023, then soared by 43541.29% to 4.08 in 2024, then tumbled by 99.91% to 0.0 in 2025.
  • Per Business Quant data, the three most recent Debt Ratio figures were 0.0 in Q3 2025, 0.01 in Q1 2025, and 4.08 in Q3 2024.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Debt Ratio (Qtr)
1 Haleon 87.22 Bn 85.35 Bn - 0.26
2 Teva Pharmaceutical Industries 39.60 Bn 35.87 Bn 1.97 Bn 0.42
3 Zoetis 31.46 Bn 29.52 Bn 1.62 Bn 0.60
4 Takeda Pharmaceutical 26.49 Bn 22.44 Bn 4.39 Bn 0.29
5 United Therapeutics 23.03 Bn 20.88 Bn 648.10 Mn -
6 Universe Pharmaceuticals 23.03 Bn -10.56 Bn - 0.10
7 Viatris 20.90 Bn 19.09 Bn 1.16 Bn 0.39
8 Neurocrine Biosciences 17.50 Bn 16.19 Bn 800.70 Mn -
9 Elanco Animal Health 12.33 Bn 11.91 Bn 785.00 Mn 0.29
10 Bgm 45.84 Mn 37.04 Mn - 0.00

Historic Data

Download Data
DateValue
Sep 30, 2025 0.00
Mar 31, 2025 0.01
Sep 30, 2024 4.08
Sep 30, 2023 0.01
Sep 30, 2022 0.00
Mar 31, 2022 39.34 Bn
Sep 30, 2020 0.15
Sep 30, 2019 0.14